Overview

Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 Patients

Status:
Completed
Trial end date:
2021-07-30
Target enrollment:
Participant gender:
Summary
This research is a study that compares the administration of N-acetylcysteine at various doses with the outcomes of COVID-19 patients, namely the neutrophil-to-lymphocyte ratio and length of stay.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Universitas Sebelas Maret
Treatments:
Acetylcysteine
N-monoacetylcystine